Aristo Bio-Tech IPO vs DHARNI Capital IPO

Comparison between Aristo Bio-Tech IPO and DHARNI Capital IPO.

IPO Details

Aristo Bio-Tech IPO is a SME Fixed Price IPO proposed to list at NSE SME while DHARNI Capital IPO is a SME Fixed Price proposed to list at BSE SME.

Issue Size and Price

The total issue size of Aristo Bio-Tech IPO is up to ₹12.40 Cr whereas the issue size of the DHARNI Capital IPO is up to ₹10.20 Cr. The final issue price of Aristo Bio-Tech IPO is ₹72.00 per share and of DHARNI Capital IPO is ₹20.00 per share.

 Aristo Bio-Tech IPODHARNI Capital IPO
Face Value₹10 per share₹1 per share
Issue Price (Final)₹72.00 per share₹20.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size1600 shares6000 shares
Fresh Issue Size17,21,600 shares51,00,000 shares
Fresh Issue Size (Amount)up to ₹12.40 Crup to ₹10.20 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total17,21,600 shares51,00,000 shares
Issue Size Total (Amount)up to ₹12.40 Crup to ₹10.20 Cr

IPO Timetable

Aristo Bio-Tech IPO opens on Jan 16, 2023, while DHARNI Capital IPO opens on Jan 18, 2023. The closing date of Aristo Bio-Tech IPO and DHARNI Capital IPO is Jan 19, 2023, and Jan 20, 2023, respectively.

 Aristo Bio-Tech IPODHARNI Capital IPO
Issue OpenJan 16, 2023Jan 18, 2023
Issue CloseJan 19, 2023Jan 20, 2023
Basis Of Allotment (Tentative)Jan 24, 2023Jan 25, 2023
Initiation of Refunds (Tentative)Jan 25, 2023Jan 27, 2023
Credit of Share (Tentative)Jan 27, 2023Jan 30, 2023
Listing date (Tentative)Jan 30, 2023Jan 31, 2023

Financials & KPIs

Aristo Bio-Tech IPO P/E ratio is 9.46, as compared to DHARNI Capital IPO P/E ratio of 34.48.

 Aristo Bio-Tech IPODHARNI Capital IPO
Financials

Company Financials (Restated)

Period Ended30 Sep 202231 Mar 202231 Mar 202131 Mar 2020
Assets108.6977.0081.4287.85
Total Income129.07166.03167.23201.24
Profit After Tax2.591.461.081.01
NET Worth17.4314.8413.3812.31
Reserves and Surplus12.449.858.397.31
Total Borrowing29.3625.4822.2519.71
Amount in ₹ Crore

Company Financials (Restated Standalone)

Period Ended30 Sep 202231 Mar 202231 Mar 202131 Mar 2020
Assets2.932.450.250.19
Total Income3.0514.692.550.20
Profit After Tax0.590.970.150.01
NET Worth2.862.270.11-0.04
Reserves and Surplus0.000.000.000.00
Total Borrowing0.000.000.090.22
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)100%100%
Promoter Shareholding (Post-Issue)73.37%73.64%
P/E Ratio9.4634.48
Market Cap₹49.02 Cr.₹40.74 Cr.
ROE29.26
ROCE35.64
Debt/Equity5.10
EPS₹2.93₹5.46
RoNW1042.6

Shares Offered

In the Aristo Bio-Tech IPO Retail Individual Investors (RII) are offered 8,60,800 shares while in DHARNI Capital IPO retail investors are offered 8,60,800 shares. Qualified Institutional Buyers (QIB) are offered in Aristo Bio-Tech IPO and in DHARNI Capital IPO.

 Aristo Bio-Tech IPODHARNI Capital IPO
Market Maker Reservation91,200 shares2,70,000 shares
NII8,60,800 shares25,50,000 shares
RII8,60,800 shares25,50,000 shares
Total17,21,600 shares51,00,000 shares

Bids Received (Subscription)

Aristo Bio-Tech IPO subscribed 217.72x in total, whereas DHARNI Capital IPO subscribed 6.57x.

 Aristo Bio-Tech IPODHARNI Capital IPO
NII (times)285.84x6.32x
RII (times)149.59x6.83x
Total (times)217.72x6.57x

Compare with others

Compare: